SNHG5 and cancer: The findings indicated that elevated SNHG5 expression was associated with a poorer cancer prognosis, specifically in patients with nondigestive system cancers (HR = 2.54, 95% CI 1.18–5.48); multivariate analysis was also performed (HR = 4.84, 95% CI 2.42–9.70), and the mean cutoff value was 2.82, 95% CI 1.13–7.04.